Link to easier reading of: Early diagnosis of type 2 diabetes
Japanese trial 2018
"Insulin resistance was correlated with
1- fasting levels of insulin and
2- leptin/adiponectin (r = 0.913);
3-retinol binding protein 4 and
4-glycated albumin"
" However, the OGTT is a time-consuming and invasive test."
"Adiponectin and leptin are secreted exclusively by adipose tissue andact as hormones with antagonistic effects."
"The results of this study demonstrate that multiple markers including
1- insulin,
2- leptin/adiponectin,(ratio) and
3- 10- and 12-Z,E-HODE/LA
can be used to detect diabetes risk at an early stage."
" Leptin has pro-inflammatory effects while adiponectin has insulin-sensitizing
and anti-inflammatory properties.
and anti-inflammatory properties.
" It is therefore reasonable that L/A(leptin to adiponectin ratio) is
highly correlated with insulin levels during the OGTT. "
highly correlated with insulin levels during the OGTT. "
"In contrast, quantitative measurements and immunological assays for our biomarkers
(i.e., insulin, adiponectin and leptin) are much easier to perform. "
(i.e., insulin, adiponectin and leptin) are much easier to perform. "
"We believe that these multiple biomarkers will provide sufficient information
to detect diabetes risk during annual health examinations.
to detect diabetes risk during annual health examinations.
Lifestyle modification or pharmacotherapy with metformin plus low-dose pioglitazone
has been recommended for patients with IFG ± IGT.(23)"
has been recommended for patients with IFG ± IGT.(23)"
"The results presented here confirm the robustness and effectiveness of our proposed algorithm, which can predict
1- diabetes risk,
2- glucose tolerance, and
3-insulin resistance
before diabetes onset.
At a minimum, the algorithm consisted of
1-fasting plasma insulin and
2-leptin/adiponectin levels, and preferably
3- 10- and 12-Z,E-HODE levels.
In addition, the OGTT was useful when insulin data were obtained.
However, given that the OGTT is a time-consuming, invasive and
inconvenient test that is limited to healthy individuals, we propose that it
be replaced by a more convenient annual health examination that measures
only the 4 fasting plasma biomarkers confirmed in this study,
which are more reliable than plasma levels of
HbA1c that reflect the accumulation of 3 months of physical conditioning."
inconvenient test that is limited to healthy individuals, we propose that it
be replaced by a more convenient annual health examination that measures
only the 4 fasting plasma biomarkers confirmed in this study,
which are more reliable than plasma levels of
HbA1c that reflect the accumulation of 3 months of physical conditioning."
Conventional advise from Medical literature for clinical practice
UpToDate:
Insulin levels not advised with OGTT(oral glucose tolerance test) or with fasting glucose(see bottom)
Prevention of type 2 diabetes mellitus
Literature review current through: Mar 2018
- Authors:
- David K McCulloch, MD
- R Paul Robertson, MD
- Section Editor:
- David M Nathan, MD
- Deputy Editor:
- Jean E Mulder, MD
INTRODUCTION
"Type 2 diabetes mellitus is characterized by
1-hyperglycemia,
2- insulin resistance, and
3-relative impairment in insulin secretion.
Although the lifetime risk of type 2 diabetes is high, our ability to predict and prevent type 2 diabetes in the general population is limited.
However, individuals at high risk, including those with
1- impaired fasting glucose (IFG),
2-impaired glucose tolerance (IGT),
3-obesity,
4-close relatives with type 2 diabetes, or who are
4-members of certain ethnic groups (Asian, Hispanic, African American),
are appropriate candidates for preventive interventions [1]"
My opinion: These high risk patients should be started on metformin.
If also obese, they should also be given after maximum dose of metformin tolerated.
In large population epidemiology studies,
simple ratios derived from fasting insulin and glucose
1-glucose to insulin ratios,
2-homeostasis model assessment of insulin resistance [HOMA-IR or HOMA])
have been extensively used.
There are limitations to their use, including
1- lack of a standardized universal insulin assay, and
2-lack of data demonstrating that markers of insulin resistance predict response to treatment.
As a result, although indexes such as HOMA, quantitative insulin sensitivity check index (QUICKI), etc, have been proposed and cut-points identified [11],
none are recommended for routine assessment of insulin resistance in the clinic.
No comments:
Post a Comment